XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Condensed Consolidating Financial Information
9 Months Ended
Sep. 30, 2017
Condensed Financial Information [Abstract]  
Supplemental Condensed Consolidating Financial Information
Supplemental Condensed Consolidating Financial Information
The 5.375% Notes described in Note 7, “Debt,” are fully and unconditionally guaranteed by certain of our 100% owned subsidiaries on a joint and several basis, with certain exceptions considered customary for such guarantees. The 5.375% Notes and the guarantees are effectively subordinated to all of our and our guarantors’ existing and future secured debt to the extent of the assets securing such debt. In addition, the 5.375% Notes and the guarantees are structurally subordinated to all indebtedness and other liabilities and preferred stock, if any, of our subsidiaries that do not guarantee the 5.375% Notes.
As discussed in Note 7, “Debt,” the First Amendment to the Credit Facility provided that all guarantors immediately prior to January 3, 2017, other than Molina Information Systems, LLC, d/b/a Molina Medicaid Solutions, Molina Pathways, LLC, and Pathways Health and Community Support LLC, were automatically and unconditionally released from their obligations as guarantors under the Credit Facility and the 5.375% Notes.
The following condensed consolidating financial statements present Molina Healthcare, Inc. (as parent guarantor), the subsidiary guarantors, the subsidiary non-guarantors and eliminations, according to the guarantor structure as assessed at the most recent balance sheet date, September 30, 2017.
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
 
Three Months Ended September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
380

 
$
47

 
$
4,983

 
$
(379
)
 
$
5,031

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
3

 

 
4,217

 

 
4,220

Cost of service revenue

 
42

 
81

 

 
123

General and administrative expenses
244

 
(1
)
 
519

 
(379
)
 
383

Premium tax expenses

 

 
106

 

 
106

Depreciation and amortization
23

 
1

 
9

 

 
33

Impairment losses

 
28

 
101

 

 
129

Restructuring and separation costs
77

 
8

 
33

 

 
118

Total operating expenses
347

 
78

 
5,066

 
(379
)
 
5,112

Operating income (loss)
33

 
(31
)
 
(83
)
 

 
(81
)
Interest expense
32

 

 

 

 
32

Income (loss) before income taxes
1

 
(31
)
 
(83
)
 

 
(113
)
Income tax expense (benefit)
9

 
(10
)
 
(15
)
 

 
(16
)
Net loss before equity in net losses of subsidiaries
(8
)
 
(21
)
 
(68
)
 

 
(97
)
Equity in net losses of subsidiaries
(89
)
 
(77
)
 

 
166

 

Net loss
$
(97
)
 
$
(98
)
 
$
(68
)
 
$
166

 
$
(97
)


CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE LOSS
 
Three Months Ended September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net loss
$
(97
)
 
$
(98
)
 
$
(68
)
 
$
166

 
$
(97
)
Other comprehensive loss, net of tax

 

 

 

 

Comprehensive loss
$
(97
)
 
$
(98
)
 
$
(68
)
 
$
166

 
$
(97
)


CONDENSED CONSOLIDATING STATEMENTS OF INCOME
 
Three Months Ended September 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
274

 
$
48

 
$
4,498

 
$
(274
)
 
$
4,546

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
19

 

 
3,730

 
(1
)
 
3,748

Cost of service revenue

 
42

 
77

 

 
119

General and administrative expenses
223

 
(4
)
 
397

 
(273
)
 
343

Premium tax expenses

 

 
127

 

 
127

Health insurer fee expenses

 

 
55

 

 
55

Depreciation and amortization
25

 
2

 
9

 

 
36

Total operating expenses
267

 
40

 
4,395

 
(274
)
 
4,428

Operating income
7

 
8

 
103

 

 
118

Interest expense
26

 

 

 

 
26

(Loss) income before income taxes
(19
)
 
8

 
103

 

 
92

Income tax expense
4

 

 
46

 

 
50

Net (loss) income before equity in net earnings of subsidiaries
(23
)
 
8

 
57

 

 
42

Equity in net earnings of subsidiaries
65

 

 

 
(65
)
 

Net income
$
42

 
$
8

 
$
57

 
$
(65
)
 
$
42



CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
 
Three Months Ended September 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Net income
$
42

 
$
8

 
$
57

 
$
(65
)
 
$
42

Other comprehensive loss, net of tax
(1
)
 

 
(1
)
 
1

 
(1
)
Comprehensive income
$
41

 
$
8

 
$
56

 
$
(64
)
 
$
41


CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
 
Nine Months Ended September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
1,010

 
$
146

 
$
14,792

 
$
(1,014
)
 
$
14,934

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
10

 

 
12,812

 

 
12,822

Cost of service revenue

 
127

 
242

 

 
369

General and administrative expenses
799

 
13

 
1,429

 
(1,014
)
 
1,227

Premium tax expenses

 

 
331

 

 
331

Depreciation and amortization
75

 
1

 
33

 

 
109

Impairment losses

 
28

 
173

 

 
201

Restructuring and separation costs
120

 
8

 
33

 

 
161

Total operating expenses
1,004

 
177

 
15,053

 
(1,014
)
 
15,220

Operating income (loss)
6

 
(31
)
 
(261
)
 

 
(286
)
Interest expense
85

 

 

 

 
85

Other income, net
(75
)
 

 

 

 
(75
)
Loss before income taxes
(4
)
 
(31
)
 
(261
)
 

 
(296
)
Income tax expense (benefit)
26

 
(10
)
 
(62
)
 

 
(46
)
Net loss before equity in net losses of subsidiaries
(30
)
 
(21
)
 
(199
)
 

 
(250
)
Equity in net losses of subsidiaries
(220
)
 
(143
)
 

 
363

 

Net loss
$
(250
)
 
$
(164
)
 
$
(199
)
 
$
363

 
$
(250
)


CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE LOSS
 
Nine Months Ended September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net loss
$
(250
)
 
$
(164
)
 
$
(199
)
 
$
363

 
$
(250
)
Other comprehensive income, net of tax
1

 

 
1

 
(1
)
 
1

Comprehensive loss
$
(249
)
 
$
(164
)
 
$
(198
)
 
$
362

 
$
(249
)

CONDENSED CONSOLIDATING STATEMENTS OF INCOME
 
Nine Months Ended September 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
786

 
$
147

 
$
13,099

 
$
(784
)
 
$
13,248

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
50

 

 
10,881

 
(1
)
 
10,930

Cost of service revenue

 
130

 
232

 

 
362

General and administrative expenses
659

 
5

 
1,153

 
(783
)
 
1,034

Premium tax expenses

 

 
345

 

 
345

Health insurer fee expenses

 

 
163

 

 
163

Depreciation and amortization
70

 
5

 
27

 

 
102

Total operating expenses
779

 
140

 
12,801

 
(784
)
 
12,936

Operating income
7

 
7

 
298

 

 
312

Interest expense
76

 

 

 

 
76

(Loss) income before income taxes
(69
)
 
7

 
298

 

 
236

Income tax (benefit) expense
(24
)
 
(1
)
 
162

 

 
137

Net (loss) income before equity in earnings of subsidiaries
(45
)
 
8

 
136

 

 
99

Equity in net earnings of subsidiaries
144

 
3

 

 
(147
)
 

Net income
$
99

 
$
11

 
$
136

 
$
(147
)
 
$
99



CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME
 
Nine Months Ended September 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
99

 
$
11

 
$
136

 
$
(147
)
 
$
99

Other comprehensive income, net of tax
7

 

 
6

 
(6
)
 
7

Comprehensive income
$
106

 
$
11

 
$
142

 
$
(153
)
 
$
106

CONDENSED CONSOLIDATING BALANCE SHEETS
 
September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
356

 
$
58

 
$
3,520

 
$

 
$
3,934

Investments
35

 

 
1,752

 

 
1,787

Restricted investments
326

 

 

 

 
326

Receivables
2

 
25

 
975

 

 
1,002

Income taxes refundable
2

 

 
58

 

 
60

Due from (to) affiliates
203

 
(5
)
 
(198
)
 

 

Prepaid expenses and other current assets
65

 
20

 
89

 

 
174

Derivative asset
425

 

 

 

 
425

Total current assets
1,414

 
98

 
6,196

 

 
7,708

Property, equipment, and capitalized software, net
261

 
37

 
99

 

 
397

Deferred contract costs

 
97

 

 

 
97

Goodwill and intangible assets, net
55

 
43

 
433

 

 
531

Restricted investments

 

 
117

 

 
117

Investment in subsidiaries, net
2,625

 
95

 

 
(2,720
)
 

Deferred income taxes
10

 

 
96

 
(44
)
 
62

Other assets
50

 
2

 
6

 
(16
)
 
42

 
$
4,415

 
$
372

 
$
6,947

 
$
(2,780
)
 
$
8,954

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$

 
$

 
$
2,478

 
$

 
$
2,478

Amounts due government agencies

 

 
1,324

 

 
1,324

Accounts payable and accrued liabilities
227

 
40

 
218

 

 
485

Deferred revenue

 
52

 
416

 

 
468

Current portion of long-term debt
782

 

 

 

 
782

Derivative liability
425

 

 

 

 
425

Total current liabilities
1,434

 
92

 
4,436

 

 
5,962

Long-term debt
1,515

 

 
16

 
(16
)
 
1,515

Deferred income taxes
12

 
32

 

 
(44
)
 

Other long-term liabilities
25

 
1

 
22

 

 
48

Total liabilities
2,986

 
125

 
4,474

 
(60
)
 
7,525

Total stockholders’ equity
1,429

 
247

 
2,473

 
(2,720
)
 
1,429

 
$
4,415

 
$
372

 
$
6,947

 
$
(2,780
)
 
$
8,954


CONDENSED CONSOLIDATING BALANCE SHEETS
 
December 31, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
86

 
$
6

 
$
2,727

 
$

 
$
2,819

Investments
178

 

 
1,580

 

 
1,758

Receivables
2

 
34

 
938

 

 
974

Income tax refundable
17

 
4

 
18

 

 
39

Due from (to) affiliates
104

 
(5
)
 
(99
)
 

 

Prepaid expenses and other current assets
58

 
30

 
43

 

 
131

Derivative asset
267

 

 

 

 
267

Total current assets
712

 
69

 
5,207

 

 
5,988

Property, equipment, and capitalized software, net
301

 
46

 
107

 

 
454

Deferred contract costs

 
86

 

 

 
86

Goodwill and intangible assets, net
58

 
73

 
629

 

 
760

Restricted investments

 

 
110

 

 
110

Investment in subsidiaries, net
2,609

 
246

 

 
(2,855
)
 

Deferred income taxes
10

 

 

 

 
10

Other assets
48

 
3

 
6

 
(16
)
 
41

 
$
3,738

 
$
523

 
$
6,059

 
$
(2,871
)
 
$
7,449

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$
1

 
$

 
$
1,928

 
$

 
$
1,929

Amounts due government agencies

 

 
1,202

 

 
1,202

Accounts payable and accrued liabilities
146

 
34

 
205

 

 
385

Deferred revenue

 
40

 
275

 

 
315

Current portion of long-term debt
472

 

 

 

 
472

Derivative liability
267

 

 

 

 
267

Total current liabilities
886

 
74

 
3,610

 

 
4,570

Long-term debt
1,173

 

 
16

 
(16
)
 
1,173

Deferred income taxes
11

 
39

 
(35
)
 

 
15

Other long-term liabilities
19

 
1

 
22

 

 
42

Total liabilities
2,089

 
114

 
3,613

 
(16
)
 
5,800

Total stockholders’ equity
1,649

 
409

 
2,446

 
(2,855
)
 
1,649

 
$
3,738

 
$
523

 
$
6,059

 
$
(2,871
)
 
$
7,449

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
 
Nine Months Ended September 30, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
215

 
$
81

 
$
661

 
$

 
$
957

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(333
)
 

 
(1,563
)
 

 
(1,896
)
Proceeds from sales and maturities of investments
150

 

 
1,388

 

 
1,538

Purchases of property, equipment and capitalized software
(67
)
 
(10
)
 
(8
)
 

 
(85
)
Increase in restricted investments held-to-maturity

 

 
(10
)
 

 
(10
)
Capital contributions to/from subsidiaries
(363
)
 
2

 
361

 

 

Dividends to/from subsidiaries
136

 

 
(136
)
 

 

Change in amounts due to/from affiliates
(100
)
 

 
100

 

 

Other, net

 
(21
)
 

 

 
(21
)
Net cash (used in) provided by investing activities
(577
)
 
(29
)
 
132

 

 
(474
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offering, net of issuance costs
325

 

 

 

 
325

Proceeds from borrowings under credit facility
300

 

 

 

 
300

Proceeds from employee stock plans
11

 

 

 

 
11

Other, net
(4
)
 

 

 

 
(4
)
Net cash provided by financing activities
632

 

 

 

 
632

Net increase in cash and cash equivalents
270

 
52

 
793

 

 
1,115

Cash and cash equivalents at beginning of period
86

 
6

 
2,727

 

 
2,819

Cash and cash equivalents at end of period
$
356

 
$
58

 
$
3,520

 
$

 
$
3,934



CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS


 
Nine Months Ended September 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
43

 
$
34

 
$
556

 
$

 
$
633

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(114
)
 

 
(1,330
)
 

 
(1,444
)
Proceeds from sales and maturities of investments
103

 

 
1,409

 

 
1,512

Purchases of property, equipment and capitalized software
(102
)
 
(23
)
 
(18
)
 

 
(143
)
Decrease in restricted investments held-to-maturity

 

 
4

 

 
4

Net cash paid in business combinations

 
(5
)
 
(43
)
 

 
(48
)
Capital contributions to/from subsidiaries
(221
)
 
7

 
214

 

 

Dividends to/from subsidiaries
50

 

 
(50
)
 

 

Change in amounts due to/from affiliates
(12
)
 
4

 
8

 

 

Other, net
6

 
(19
)
 
1

 

 
(12
)
Net cash (used in) provided by investing activities
(290
)
 
(36
)
 
195

 

 
(131
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from employee stock plans

10

 

 

 

 
10

Other, net
2

 

 
(1
)
 

 
1

Net cash provided by (used in) financing activities
12

 

 
(1
)
 

 
11

Net (decrease) increase in cash and cash equivalents
(235
)
 
(2
)
 
750

 

 
513

Cash and cash equivalents at beginning of period
360

 
13

 
1,956

 

 
2,329

Cash and cash equivalents at end of period
$
125

 
$
11

 
$
2,706

 
$

 
$
2,842